RBC
ZBH icon

Romano Brothers & Co’s Zimmer Biomet ZBH Stock Holding History

Romano Brothers & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$631K Sell
7,333
-200
-3% -$17.5K 0.06% 215
2026
Q1 		$681K Hold
7,533
– – 0.08% 199
2025
Q4 		$677K Sell
7,533
-446
-6% -$42.3K 0.08% 199
2025
Q3 		$786K Sell
7,979
-550
-6% -$54.5K 0.09% 187
2025
Q2 		$778K Sell
8,529
-445
-5% -$43K 0.1% 184
2025
Q1 		$1.02M Sell
8,974
-492
-5% -$52.6K 0.13% 157
2024
Q4 		$1,000K Buy
9,466
+102
+1% +$10.9K 0.13% 159
2024
Q3 		$1.01M Hold
9,364
– – 0.13% 159
2024
Q2 		$1.02M Sell
9,364
-150
-2% -$17.7K 0.14% 150
2024
Q1 		$1.26M Buy
9,514
+100
+1% +$12.5K 0.17% 140
2023
Q4 		$1.15M Sell
9,414
-500
-5% -$55.8K 0.17% 137
2023
Q3 		$1.11M Hold
9,914
– – 0.17% 141
2023
Q2 		$1.44M Sell
9,914
-125
-1% -$17K 0.22% 122
2023
Q1 		$1.3M Hold
10,039
– – 0.2% 125
2022
Q4 		$1.28M Sell
10,039
-150
-1% -$17.4K 0.19% 122
2022
Q3 		$1.06M Buy
+10,189
New +$1.12M 0.17% 136

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Romano Brothers & Co's ZBH Position: Q2 2026 in Review

Romano Brothers & Co reduced its Zimmer Biomet (ZBH) stake by 2.7% in Q2 2026, selling an estimated $17.5K and leaving 7,333 shares worth $631K. The position accounts for 0.06% of the portfolio, ranked #215.

Romano Brothers & Co first reported a position in ZBH in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.44M in Q2 2023. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Romano Brothers & Co held 7,333 shares of Zimmer Biomet worth $631K as of Q2 2026.
  • Romano Brothers & Co sold 200 Zimmer Biomet shares in Q2 2026, an estimated $17.5K.
  • Zimmer Biomet made up 0.06% of Romano Brothers & Co's portfolio in Q2 2026, its #215 holding.
  • Romano Brothers & Co first reported a position in Zimmer Biomet in Q3 2022 and has held it in 16 quarters since.
  • Romano Brothers & Co's Zimmer Biomet position peaked at $1.44M in Q2 2023.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.